RAPID RESPONSE FROM BMJ.COM

BMJ 2005; 330 doi: 10.1136/bmj.330.7492.E341 (Published 17 March 2005)
Cite this as: BMJ 2005;330:E341

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Patrick W Sullivan, assistant professor
  1. University of Colorado School of Pharmacy Pharmaceutical Outcomes Research Program Denver, CO

    Following is an edited excerpt from one of the Rapid Responses generated by this article, all of which can be read in their entirety athttp://bmj.bmjjournals.com/cgi/eletters/330/7481/39.—Editor

    Cohen et al state that switching drugs to over the counter availability increases costs for most insured patients in the United States, but we have shown that the Rx-to-OTC switch …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL